Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing’s disease
Abstract
Purpose Nighttime salivary cortisol (NSC) has been proposed for the diagnosis of Cushing's syndrome during pregnancy. However, reference values for NCS in pregnant women have not been adequately determined. The aim of this study was to determine the reference values of NSC in the three gestational trimesters in order to help distinguish physiological from pathological hypercortisolism during pregnancy. Methods This prospective and retrospective study evaluated 85 pregnant women in whom samples were collected in the first, second and/or third gestational trimester (pregnancy group), 33 non-pregnant women (control group), and 25 non-pregnant women with Cushing's disease (CD group). NSC was measured by enzyme-linked immunosorbent assay. Results NSC increased progressively during pregnancy, reaching maximum levels on the third trimester (median 2.1-fold increase compared with controls, p < 0.001). Reference values for NSC were determined and the upper limits on each gestational trimester were: first trimester 0.25 µg/dL (6.9 nmol/L), second trimester 0.26 µg/dL (7.2 nmol/L), and third trimester 0.33 µg/dL (9.1 nmol/L). Cutoff values that separated the CD group from the three trimesters in the pregnancy groups were, respectively, 0.255 µg/dL (7.0 nmol/L), 0.260 µg/dL (7.2 nmol/L), and 0.285 µg/dL (7.9 nmol/L). Comparison of NSC cutoff values in pregnant women with CD patients showed high sensitivity and specificity in all three trimesters. Conclusions We established cutoff values for determination of NSC which can be useful for pregnant women with a diagnostic suspicion of CD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the study of Lopes et al, the reference range for LNSC in each gestational trimester were 0.03 to 0.25 μg/dL in the first trimester, 0.04 to 0.26 μg/dL in the second trimester, and 0.07 to 0.33 μg/dL in the third trimester.
“In the study of Lopes et al (95), the reference range for the LNSC in each gestational trimester were 0.03 to 0.25 µg/dL (0.8-6.9 nmol/L) in the first trimester, 0.04 to 0.26 µg/dL (1.1-7.2 nmol/L) in the second trimester, and 0.07 to 0.33 µg/dL (1.7-9.1 nmol/L) in the third trimester.”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [95]
In the study of Lopes et al, the cutoff values for the diagnosis of Cushing disease were 0.255 μg/dL for the first trimester, 0.260 μg/dL for the second trimester, and 0.285 μg/dL for the third trimester.
“The cutoff values for the diagnosis of Cushing disease in the study were 0.255 µg/dL (7.0 nmol/L) for the first trimester, 0.260 µg/dL (7.2 nmol/L) for the second trimester, and 0.285 µg/dL (7.9 nmol/L) for the third trimester (90, 95).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [95]
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 3× · see citing works
“Among the first-line tests, LDDST should not be considered the first choice in pregnant women due to false positive results during pregnancy, a consequence of impaired response to dexamethasone [7].”
BackgroundEffect of four different oral contraceptives on various sex hormones and serum-binding globulins
Wiegratz, I., Kutschera, E., Lee, J. H., Moore, C., Mellinger, U., Winkler, U. H., & Kuhl, H. (2003) · Contraception · doi:10.1016/s0010-7824(02)00436-5 · Cited by 239 · see citing works
Viardot, A., Huber, P., Puder, J. J., Zulewski, H., Keller, U., & Müller, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2264 · Cited by 172 · see citing works
Baid, S. K., Sinaii, N., Wade, M., Rubino, D., & Nieman, L. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2861 · Cited by 144 · see citing works
Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome
Carroll, T., Raff, H., & Findling, J. W. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0837 · Cited by 97 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Findling, J. W., & Raff, H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0946 · Cited by 134 · see citing works
Pofi, R., & Tomlinson, J. (2019) · Obstetric Medicine · doi:10.1177/1753495x19847832 · Cited by 63 · see citing works
“However, late night salivary cortisol may be more helpful, especially during the first and the second trimesters.(43) The placental secretion of ACTH and CRH can lead to a failure of suppression of pituitary ACTH levels in 50% of women with adrenal CS.”
Accuracy of laboratory tests for the diagnosis of Cushing syndrome
Galm, B. P., Qiao, N., Klibanski, A., Biller, B. M. K., & Tritos, N. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa105 · Cited by 100 · see citing works
Diagnosis of Cushing’s Syndrome in the Modern Era
Nieman, L. K. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.001 · Cited by 93 · see citing works
Approach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91 · see citing works
“9 nmol/L) for the third trimester (90, 95).”
BackgroundBrue, T., Amodru, V., & Castinetti, F. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1058 · Cited by 85 · see citing works
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy
Luger, A., Broersen, L. H. A., Biermasz, N. R., Biller, B. M. K., Buchfelder, M., Chanson, P., Jørgensen, J. O. L., Keleştimur, F., Llahana, S., Maiter, D. M., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0462 · Cited by 104 · see citing works
Nishioka, H., & Yamada, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111951 · Cited by 65 · see citing works
“Salivary and serum free cortisol levels also increase during pregnancy, particularly in the third trimester [120], by the increase in plasma ACTH levels.”
BackgroundThe diagnosis and management of Cushing's syndrome in pregnancy
Hamblin, R., Coulden, A., Fountas, A., & Karavitaki, N. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13118 · Cited by 59 · see citing works
“1-fold that of non-pregnancy levels in the third trimester.(22) However, diurnal variation in cortisol is still maintained, but the level of fluctuation from the mean becomes blunted.”
BackgroundMethodInfluentialPhysiological changes in pregnancy and their influence on the endocrine investigation
Morton, A., & Teasdale, S. (2021) · Clinical Endocrinology · doi:10.1111/cen.14624 · Cited by 49 · see citing works
“An elevated nighttime salivary cortisol is also useful in the diagnosis of CS in pregnancy.(44) ACTH levels cannot be used to differentiate between pituitary and adrenal causes of CS, as ACTH levels are not suppressed in half of adrenal CS, whereas some pregnant women with pituitary Cushing's disease have been reporte…”
BackgroundChanges in biochemical tests in pregnancy and their clinical significance
Teasdale, S., & Morton, A. (2018) · Obstetric Medicine · doi:10.1177/1753495x18766170 · Cited by 53 · see citing works
Nieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 73 · see citing works
“Hormonal changes overlap with CS in the second and third trimesters (see the figure) and trimester-specific reference ranges must be used for CS testing 264,283,284 .”
Pituitary Tumors in Pregnancy.
Huang, W., & Molitch, M. (2019) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2019.05.004 · Cited by 38 · see citing works
Biochemical diagnosis of Cushing’s disease: Screening and confirmatory testing
Petersenn, S. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101519 · Cited by 33 · see citing works
Pregnancy in Patients with Cushing's Syndrome.
Machado, M., Fragoso, M., & Bronstein, M. (2018) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2018.02.004 · Cited by 25 · see citing works
Self-citationEmerging diagnostic methods and imaging modalities in cushing’s syndrome
Wright, K. E., van Rossum, E. F. C., Zan, E., Werner, N. L., Harris, A. G., Feelders, R. A., & Agrawal, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1230447 · Cited by 25 · see citing works
“LNSC levels physiologically increase during pregnancy, up to two times the ULN in the third trimester, but in CS signi fi cantly higher cortisol levels are found (29).”
BackgroundEndogenous Cushing’s syndrome during pregnancy
Younes, N., St-Jean, M., Bourdeau, I., & Lacroix, A. (2022) · Reviews in Endocrine & Metabolic Disorders · doi:10.1007/s11154-022-09731-y · Cited by 22 · see citing works
Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome
Findling, J. W., & Raff, H. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad087 · Cited by 30 · see citing works
“Serum-free and salivary cortisol increase during pregnancy [88, 89].”
BackgroundL'impact du syndrome de Cushing sur la fertilité et la grossesse.
Castinetti, F., & Brue, T. (2022) · Annales d'Endocrinologie · doi:10.1016/j.ando.2022.04.001 · Cited by 20 · see citing works
Endocrine causes of hypertension in pregnancy.
Affinati, A. H., & Auchus, R. (2020) · Gland surgery · doi:10.21037/gs.2019.12.04 · Cited by 20 · see citing works
“1 nmol/L in the third trimester, which results in a specificity between 80% to 92% (46).”
BackgroundChronic maternal hypercortisolemia in late gestation alters fetal cardiac function at birth.
Antolic, A. T., Wood, C., & Keller-Wood, M. (2018) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.00296.2017 · Cited by 19 · see citing works
“In normal pregnant women, nighttime salivary (free) cortisol levels average 4 nM, and the upper 95% confidence limit is 7 nM; in pregnant women with Cushing’s syndrome, the evening cortisol levels average 14 nM (38).”
BackgroundPituitary Disorders in Pregnancy.
Woodmansee, W. (2019) · Neurologic clinics · doi:10.1016/j.ncl.2018.09.009 · Cited by 18 · see citing works
Surgery for Cushing's disease in pregnancy: our experience and a literature review.
Jolly, K., Darr, A., Arlt, W., Ahmed, S., & Karavitaki, N. (2019) · Annals of the Royal College of Surgeons of England · doi:10.1308/rcsann.2018.0175 · Cited by 18
Adrenal disorders in pregnancy, labour and postpartum – an overview
Manoharan, M., Sinha, P., & Sibtain, S. (2020) · Journal of Obstetrics and Gynaecology Research · doi:10.1080/01443615.2019.1648395 · Cited by 17 · see citing works
Flowers, K. C., & Shipman, K. E. (2023) · Diagnostics · doi:10.3390/diagnostics13081415 · Cited by 16 · see citing works
Jairaj, C., O'Leary, N., Doolin, K., Farrell, C., McCarthy, A., Mcauliffe, F., O'Grady-Walshe, A., Sheehan, J., & O'Keane, V. (2020) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1740318 · Cited by 14 · see citing works
Diagnosis and treatment outcomes of Cushing’s disease during pregnancy
Sridharan, K., Sahoo, J., Palui, R., Patil, M., Kamalanathan, S., Ramesh, A., & Kubera, N. (2021) · Pituitary · doi:10.1007/s11102-021-01142-7 · Cited by 13 · see citing works
Evaluation and Management of Endocrine Hypertension During Pregnancy.
Corsello, S., & Paragliola, R. (2019) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2019.08.011 · Cited by 13 · see citing works
Zhang, X., Liao, H., Zhu, X., Shi, D., & Chen, X.-P. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2262-2 · Cited by 13 · see citing works
St-Jean, M., Mackenzie-Feder, J., Bourdeau, I., & Lacroix, A. (2019) · Endocrinology, Diabetes & Metabolism Case Reports · doi:10.1530/edm-18-0115 · Cited by 8 · see citing works
Child mortality, hypothalamic-pituitary-adrenal axis activity and cellular aging in mothers
Barha, C. K., Salvante, K. G., Hanna, C. W., Wilson, S. L., Robinson, W. P., Altman, R. M., & Nepomnaschy, P. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177869 · Cited by 10 · see citing works
Conundrums of Diagnosis and Management of Cushing's Syndrome in Pregnancy.
Gheorghiu, M. L., & Fleseriu, M. (2024) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2024.05.007 · Cited by 7 · see citing works
Cushing's Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review
Wang, Y., An, Y., Hou, X.-M., Xu, Y.-N., Li, Z., Liu, X., Zheng, F.-M., Sun, M.-Z., Han, R.-D., Lu, C.-X., et al. (2024) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.474 · Cited by 7 · see citing works
“Lopes LML established upper reference limits for LNSC during pregnancy, which are 6.9, 7.2 and 9.1 nmol/L for the first, second and third trimesters, respectively [26].”
BackgroundInfluentialDesmopressin Stimulation Test in a Pregnant Patient with Cushing's Disease
Parksook, W., Porntharukchareon, T., & Sunthornyothin, S. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2021.11.005 · Cited by 6 · see citing works
Findling, J., & Raff, H. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1034 · Cited by 6 · see citing works
Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy.
Scutelnicu, A., Panaitescu, A., Ciobanu, A., Gică, N., Botezatu, R., Peltecu, G., & Gheorghiu, M. (2020) · Acta Endocrinologica · doi:10.4183/aeb.2020.511 · Cited by 6 · see citing works
“Night salivary cortisol increases 2-fold in the 3 trimester compared to nonpregnant women (14).”
BackgroundDiverse presentations of Cushing's syndrome during pregnancy – A case series
Stoinis, N., Creeper, K. J., Phillips, J., Graham, D., & Lim, E.-M. (2024) · Australian and New Zealand journal of obstetrics and gynaecology · doi:10.1111/ajo.13793 · Cited by 5 · see citing works
Surgical treatment of adrenal tumors during pregnancy
Bartz-Kurycki, M. A., Dream, S. Y., & Wang, T. S. (2022) · Reviews in Endocrine & Metabolic Disorders · doi:10.1007/s11154-022-09744-7 · Cited by 5 · see citing works
Adrenal Cortex and Medulla Physiology During Pregnancy, Labor, and Puerperium
St-Jean, M., Bourdeau, I., & Lacroix, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00008-8 · Cited by 5 · see citing works
Management of Patients with Pseudo-Endocrine Disorders: A Case-Based Pocket Guide
Mcdermott, M. (2019) · doi:10.1007/978-3-030-22720-3 · Cited by 5
“[24], a trend that has likely continued.”
BackgroundFindling, J. W., & Raff, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_6 · Cited by 4 · see citing works
Marino, M. J., & Webster, S. M. (2023) · AACE Clinical Case Reports · doi:10.1016/j.aace.2023.03.002 · Cited by 4 · see citing works
Pregnancy in patients with adrenocortical carcinoma: a case-based discussion
Puglisi, S., Basile, V., Sperone, P., & Terzolo, M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09769-y · Cited by 7 · see citing works
“1 nmol/L for the first, second, and third trimesters, respectively) [23].”
Sundararajan, A., Vora, K. S., Saiyed, S., & Natesan, S. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1551-3722 · Cited by 4 · see citing works
“mester of pregnancy, compared to non-pregnant women [10].”
BackgroundResultAdrenal disease and pregnancy: an overview
Ahmed, M., Bashir, M., Okunoye, G. O., & Konje, J. (2021) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12761 · Cited by 3 · see citing works
Cushing syndrome in pregnancy, diagnosed after delivery
Kim, H. B., Kim, M. K., Kim, E., Ahn, K., Kim, H. S., & Kim, N. K. (2020) · Yeungnam University Journal of Medicine · doi:10.12701/yujm.2020.00290 · Cited by 3
“However, a recent study showed that late-night salivary cortisol concentration is higher in patients with CS than in pregnant women [9]; therefore, the use of a combination of UFC and late-night salivary cortisol is recommended for the diagnosis of CS during pregnancy.”
BackgroundManagement of pituitary tumors during pregnancy and lactation
Glezer, A., Jallad, R., Machado, M., Fragoso, M., & Bronstein, M. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.02.002 · Cited by 3 · see citing works
Self-citationAdrenal Pathologies During Pregnancy and Postpartum
St‐Jean, M., Bourdeau, I., & Lacroix, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00025-8 · Cited by 4 · see citing works
The Pituitary Gland in Pregnancy
Glezer, A., & Bronstein, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00013-1 · Cited by 3 · see citing works
Self-citationTheodorou, A., & Geer, E. B. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf042 · Cited by 2
“In normal pregnancies, UFC levels typically increase 2-to 3-fold, while LNSC levels may remain normal, although data on this are limited [15].”
Cushing’s syndrome and pregnancy: diagnostic, treatment and management tactics
Golounina, O., Pavlova, M. G., Gronskaya, S. A., Казначеева, Т. В., Dzeranova, L., Belaya, J. E., & Fadeev, V. (2021) · Rossiiskii vestnik akushera-ginekologa · doi:10.17116/rosakush2021210515 · Cited by 2 · see citing works
Persistent vs Recurrent Cushing's Disease Diagnosed Four Weeks Postpartum
Shah, L., Nosova, E., Bederson, J., & Cheesman, K. (2022) · Case Reports in Endocrinology · doi:10.1155/2022/9236711 · Cited by 1
Pituitary Disorders During Pregnancy and Lactation
Jallad, R. S., Glezer, A., Machado, M. C., & Bronstein, M. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00018-0 · Cited by 2 · see citing works
Self-citationGandhi, C. P., McNab, T. L., Khurana, R., Tateno, T., McMullen, T., & Chik, C. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag240
“Proposed cutoffs distinguishing cortisol excess in pregnancy from physiological non-neoplastic hypercortisolism include first-trimester LNSC 7 nmol/L, second-trimester LNSC 7.2 nmol/L, and third-trimester LNSC 7.9 nmol/L, albeit this is rarely measured in PICS [14].”
InfluentialManagement of Cushing’s Disease in Pregnancy: A Case Report
Mukherjee, G., Manmathan, S., Zachariah, S., Arokisamy, J., & Kar, S. K. (2026) · Cureus · doi:10.7759/cureus.105582
“Since circadian rhythm is generally preserved, late-night salivary cortisol, using pregnancy-specific cut-off values, is considered the most useful diagnostic tool [4,5].”
Adrenal Disorders in Pregnancy.
Mathew, J., & Yeung, A. (2026) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2025.12.003
La gravidanza nelle pazienti con Sindrome di Cushing
Alessi, Y., Ferraù, F., & Cannavò, S. (2026) · L Endocrinologo · doi:10.1007/s40619-025-01736-4
“Studi dedicati hanno persino proposto valori soglia differenti per ciascun trimestre, al fine di aumentarne la precisione [13].”
A case of recurrent Cushing’s disease with optimised perinatal outcomes
Cheruvu, D., White, E., & Glastras, S. (2025) · Endocrinology, Diabetes & Metabolism Case Reports · doi:10.1530/edm-25-0092
“Lopes et al. (5) established reference values for LNSC with suggested normal ranges of 0.8 – 6.9 nmol/L in the fi rst trimester, 1.1 – 7.2 nmol/L in the second trimester, and 1.9 – 9.1 nmol/L in the third trimester (5).”
InfluentialCushing's Syndrome Missed in Pregnancy
Sudarshanan, A., Koshy, R., Mannath, S., Fernandez, C., & Jacob, K. (2024) · Cureus · doi:10.7759/cureus.70930
“The LNSC threshold values for pregnancy are defined as 6.9 nmol/L at trimester one, 7.2 nmol/L at trimester two, and 9.1 nmol/L at trimester three [14].”
BackgroundInfluentialUnveiling the Uncommon: A Case Series on Cushing’s Disease During Pregnancy
Shah, R., S, S., Suri, V., Bhadada, S., & Walia, R. (2024) · Cureus · doi:10.7759/cureus.66045
“[8].”
Addison’s disease presenting as shortness of breath and hypotension in early pregnancy
Williams, A. A., Buschmann, B., Rimu, A. H., & Phy, J. L. (2022) · The Southwest Respiratory and Critical Care Chronicles · doi:10.12746/swrccc.v10i45.1021
Research Progress in Diagnostic Methods of Cushing’s Syndrome
郭, 林. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662449
Endogenous hypercortisolism in pregnant women
Yukina, M., Chernova, M. O., Belaya, Z., Troshina, E., Platonova, N., & Beltsevich, D. (2022) · Rossiiskii vestnik akushera-ginekologa · doi:10.17116/rosakush20222202147
Management of pituitary tumors in pregnancy
Glezer, A., Jallad, R., Machado, M. C., & Bronstein, M. (2021) · Pituitary Tumors · doi:10.1016/b978-0-12-819949-7.00049-4
Self-citationPseudo-Cushing’s Syndrome: A Diagnostic Dilemma
Brown, T. V., Belokovskaya, R., & Pessah‐Pollack, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_13
- Authors
- Lopes, L. M. L., Francisco, R. P. V., Galletta, M. A. K., & Bronstein, M. D.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Lopes, Ludmilla Malveira Lima
- ORCID
- Venue
- Pituitary
- Published
- 2015-09-07
- Volume
- 19
- Issue
- 1
- Pages
- 30-38
- ISSN
- 1386-341X (ISSN-L)
- 1573-7403
- OpenAlex
- W1514123902
- Cited by
- 70
- References
- 0
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 13 · 2021: 9 · 2020: 5 · 2019: 11 · 2018: 7 · 2017: 4 · 2016: 1
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Pituitary (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- pregnancy, Cushing's disease, Cushing's syndrome, reference values, pregnancy trimesters, hypercortisolism, diagnostic thresholds, salivary biomarkers
- MeSH terms
- Circadian Rhythm, Female, Humans, Hydrocortisone, Pregnancy, Prospective Studies, Retrospective Studies, Saliva, Pituitary ACTH Hypersecretion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review